These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6698110)

  • 41. Nitrendipine: hemodynamic effects in conscious normotensive and spontaneously hypertensive rats.
    Pegram BL; Kobrin I; Sesoko S; Frohlich ED
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1016-23. PubMed ID: 6085359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beneficial effects of two forms of NO administration in feline splanchnic artery occlusion shock.
    Aoki N; Johnson G; Lefer AM
    Am J Physiol; 1990 Feb; 258(2 Pt 1):G275-81. PubMed ID: 2305894
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heterogeneity of systemic hemodynamic response to a new calcium entry blocker, nitrendipine.
    Fouad FM; Aboul-Khair M; Tarazi RC
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S383-6. PubMed ID: 6184573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Age related antihypertensive effect of nitrendipine, a new calcium entry blocking agent.
    Ferrara LA; Fasano ML; Soro S
    Eur J Clin Pharmacol; 1985; 28(4):473-4. PubMed ID: 3161743
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protective effects of a novel 21-aminosteroid during splanchnic artery occlusion shock.
    Johnson G; Lefer AM
    Circ Shock; 1990 Feb; 30(2):155-64. PubMed ID: 2311204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
    Müller FB; Bolli P; Erne P; Block LH; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1073-6. PubMed ID: 6085370
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduced cardiac mass by nitrendipine is dissociated from systemic or regional haemodynamic changes in rats.
    Kobrin I; Sesoko S; Pegram BL; Frohlich ED
    Cardiovasc Res; 1984 Mar; 18(3):158-62. PubMed ID: 6705007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcium entry blockade by nitrendipine and alpha adrenergic responsiveness in vivo: comparison with noncalcium entry blocker vasodilators in absence and presence of phenoxybenzamine pretreatment.
    Pedrinelli R; Tarazi RC
    J Pharmacol Exp Ther; 1985 Jun; 233(3):636-42. PubMed ID: 2989491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective actions of S-nitroso-N-acetylpenicillamine (SNAP) in a rat model of hemorrhagic shock.
    Symington PA; Ma XL; Lefer AM
    Methods Find Exp Clin Pharmacol; 1992 Dec; 14(10):789-97. PubMed ID: 1338473
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microcirculatory actions and uses of naturally-occurring (magnesium) and novel synthetic calcium channel blockers.
    Altura BM; Altura BT
    Microcirc Endothelium Lymphatics; 1984 Apr; 1(2):185-220. PubMed ID: 6400430
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
    Olivari MT; Levine TB; Cohn JN
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nitrendipine and other calcium entry blockers (calcium antagonists) in hypertension.
    Kazda S; Garthoff B; Knorr A
    Fed Proc; 1983 Feb; 42(2):196-200. PubMed ID: 6822291
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathophysiology of shock.
    Okada K; Kosugi I; Kitagaki T; Yamaguchi Y; Yoshikawa H
    Jpn Circ J; 1977 Apr; 41(4):346-61. PubMed ID: 875220
    [No Abstract]   [Full Text] [Related]  

  • 54. Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock.
    Bitterman H; Lefer DJ; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 Jun; 9(6):341-7. PubMed ID: 3116357
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beneficial effects of transforming growth factor-beta and tissue plasminogen activator in splanchnic artery occlusion and reperfusion in cats.
    Karasawa A; Guo JP; Ma XL; Lefer AM
    J Cardiovasc Pharmacol; 1991 Jul; 18(1):95-105. PubMed ID: 1719297
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the acute hemodynamic effects of nifedipine with nitrendipine and a study of the electrophysiological effects of nitrendipine in man.
    Rutsch W; Schmutzler H
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1011-5. PubMed ID: 6085358
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Actions of non-cardiodepressant beta-adrenergic blocking agents in hemorrhagic shock.
    Lefer AM; Lefer DJ; Levin RJ
    Adv Shock Res; 1980; 3():167-74. PubMed ID: 6118024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
    Weber MA; Drayer JI
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1077-84. PubMed ID: 6085371
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective effect of cloricromene, a coumarine derivative, in hypovolemic hemorrhagic shock in the rat.
    Sturniolo R; Squadrito F; Campo GM; Vinci R; Calatroni A; Prosdocimi M; Caputi AP
    J Cardiovasc Pharmacol; 1991 Feb; 17(2):261-6. PubMed ID: 1709231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential influence of the calcium antagonist nitrendipine and the vasodilator hydralazine on normal and elevated blood pressure.
    Knorr A; Garthoff B
    Arch Int Pharmacodyn Ther; 1984 Jun; 269(2):316-22. PubMed ID: 6476986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.